---
title: Why NAD+ or NMN IV Therapy Is Not A One Time Fix
description: "You may have seen blogs suggesting that NMN or NAD+ IV therapy is a quick fix for energy, anti-aging, or mental clarity. Unfortunately, this is misleading. While some people feel better after one session, the true benefits come with consistency…"
url: "https://dripdok.com/docs/nad-nmn-not-one-time-fix/"
updated: "2026-06-04"
category: "Our At-Home Services"
---

# Why NAD+ or NMN IV Therapy Is Not A One Time Fix

You may have seen blogs suggesting that NMN or NAD+ IV therapy is a quick fix for energy, anti-aging, or mental clarity. Unfortunately, this is misleading. While some people feel better after one session, the true benefits come with consistency over time.

## Why NAD+ Is Not a One-Time Fix

### a. NAD+ is not stored long in cells

NAD+ only lasts 6–12 hours, depending on the tissue. It’s constantly used in important processes like sirtuin activation, DNA repair (PARP enzymes), and mitochondrial ATP production. After a single infusion, NAD levels go up but return to baseline within days.

### b. NAD+ Levels Decline Over Time

- NAD+ levels drop by up to 50% by age 50 and over 80% by age 70
- Stressors like oxidative stress, inflammation, poor diet, alcohol, and overtraining all drain NAD+ stores
- Replenishing NAD+ is like filling a leaky bucket — you need to keep adding to keep it up

### c. Mitochondrial Remodeling Takes Time

Real improvements in mitochondria usually take weeks to months of sustained support with NAD+, exercise, and cofactors like CoQ10 and alpha-lipoic acid.

## Expected Timeline of Benefits

| Timeframe | Expected Outcomes |
| --- | --- |
| 6 Months | Blood markers improve (CRP, homocysteine), oxidative stress decreases, muscle recovery time improves |
| 12 Months | Mitochondrial efficiency increases, VO2 max increases, DNA damage markers decrease, HbA1c decreases |
| Biological Age (12 months) | DNA methylation clock decreases by 1–3 years, insulin sensitivity increases, systemic inflammation decreases |

## Key Takeaways

1. NAD+ and NMN IV therapy is a long-term investment in cellular health, not a quick fix
2. Sustainable benefits require 3–12 months of consistent therapy
3. Objective health metrics improve gradually — don’t confuse early subjective improvements with the full picture
4. Regular evaluation with biomarkers (HRV, inflammatory markers, DNA methylation clocks) validates progress